MC Pharma

MC Pharma (Pty) Ltd. is a specialist pharmaceutical company based in South Africa that acts as a local Applicant and Holder of the Registration Certificate (Marketing Authorisation Holder) on behalf of international product owners. Licensed under Section 22C of the Medicines and Related Substances Act, the company provides comprehensive regulatory affairs consulting, dossier submissions, and market entry strategies for the African market. MC Pharma is notable for securing the full registration of the Sinopharm COVID-19 vaccine (referred to locally as the COVID-19 Vaccine MC Pharma) with the South African Health Products Regulatory Authority (SAHPRA). The company operates as part of the MC Pharma Group, offering tailored services in regulatory intelligence, pharmacovigilance, and commercialization support without directly owning or wholesaling the products.